[Whitepaper] Q2 2019 Biopharma licensing report

Get your copy of the Q2 2019 Biopharma licensing report to understand the fast paced ever changing licensing landscape and power your deal strategy with the right insights to drive success ahead of your competition. Get insights Like:
  • Breakdown of the 18 high-value licensing deals that took place, each worth in excess of $500 million
  • Oncology deals spend and breakdown
  • Top APAC license deals
  • Third quarter 2019 outlook


Sponsored by: